DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20160044

Study of cervical pap smears in a tertiary care hospital of south Gujarat, India

Hemali J. Tailor, Patel R.D., Prashant R. Patel, Vasudha M. Bhagat

Abstract


Background: In India cervical cancer is the leading cause of morbidity and mortality. Cancer of cervix is preventable, and can be diagnosed at the pre-malignant/pre-invasive stage with adequate and repetitive cytological screening by Papanicolaou (Pap) smears.  

Methods: The prospective study includes total 1425 patients who were presented with various gynecological problems. Samples were taken and prepared smear were stained with PAP stain. Reporting was carried out by two independent cytopathologist as per Bethesda system.

Results: Total 1425 patients were screened; there were 1034 (72.56%) abnormal Pap smears, with 354 (24.84%) normal cases and 37 (2.59%) unsatisfactory or inadequate samples. Total 27 (1.89%) cases showed epithelial cell abnormalities. ASCUS was the most commonly found (40.74%) epithelial cell abnormality out of 27 cases.

Conclusions: Incidence of invasive cervical malignancy can be prevented if Pap screening program is effectively implemented in target population.


Keywords


Pap smear, Epithelial cell abnormality, ASCUS

Full Text:

PDF

References


ICO Information Centre on HPV and cancer. Human Papillomavirus and Related Diseases in India (Summary Report 2014-08-22). 2014.

Bamanikar SA, Baravkar DS, Chandanwale SS, dapkekar P. Study of Cervical Pap Smears in a Tertiary Hospital. Indian Medical Gazette. 2014:250-254.

Toews HA. The abnormal pap smear: A rationale for follow up. Can Fam Physician. 1983;29:759-62.

Maryem A, Ghazala M, Arif, HA, Tamkin K. Smear Pattern and Spectrum of Premalignant and Malignant Cervical Epithelial Lesions in Postmenopausal Indian Women: A Hospital Based Study. Diagnostic Cytopathology. 2011;40(11):976-83.

Kalkar RA, Kulkarini Y. Screening for cervical cancer: an overview. Obstet Gynecol India. 2006;56(2):115-22.

Khan MS, Raja FY, Ishfaq G, Tahir F, Subhan F,Kazi BM et al. Pap smear Screening for Precancerous conditions of the cervical cancers. Pak J. Med. Res. 2005;44(3):111-3.

Ranabhat, SK, Shrestha R, Tiwari M. Analysis of abnormal epithelial lesions in cervical Pap smears in Mid-Western Nepal. Journal of Pathology of Nepal. 2011;1:30-3.

Turkish Cervical Cancer And Cervical Cytology Research Group: Prevalence of cervical cytological abnormalities in Turkey. Int J Gynaecol Obstet. 2009;106:206-9.

Ghaith JE, Rizwana BS. Rate of Opportunistic Pap smear Screening and Patterns of Epithelial Cell Abnormalities in Pap Smears in Ajman, United Arab Emirates. Sultan Qaboos Univ Med J. 2012;12(4):473-8.

Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam S, Cain et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. Journal of Lower Genital Tract Disease. 2012;16(3):175-204.

Edelman M, Fox A. Cervical Papanicolau smear abnormalities in inner Bronx adolescents: Prevalence, progression, and immune modifiers. Cancer (cancer cytopathology). 1999;87:184-9.

Banik U, Bhattacharjee P, Ahamad SU, Rahman Z. Pattern of epithelial cell abnormality in Pap smear: A clinicopathological and demographic correlation. Cyto Journal. 2011;8:8.